US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist

3.675
+0.155+4.40%

Trading Dec 31 10:07 ET

335.08MMarket Cap-8.09P/E (TTM)

Aquestive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-405.96%-11.88M

11.39%-7.01M

-217.79%-10.38M

35.02%-6.38M

-158.71%-4.94M

-183.59%-2.35M

-20.50%-7.91M

160.88%8.82M

70.23%-9.82M

204.40%8.42M

Net income from continuing operations

-465.55%-11.51M

52.61%-2.75M

-259.00%-12.83M

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

Operating gains losses

----

--1.03M

----

Depreciation and amortization

-39.54%159K

-29.07%205K

-36.31%207K

-43.65%1.35M

17.88%468K

-55.87%263K

-56.67%289K

-55.30%325K

-19.47%2.39M

-45.69%397K

Other non cash items

2,996.59%2.73M

4,430.77%2.36M

1,425.98%2.71M

-69.76%1.77M

3,492.59%1.83M

-96.05%88K

-97.25%52K

-111.49%-204K

-62.73%5.85M

-102.88%-54K

Change In working capital

-236.26%-4.83M

-170.85%-8.36M

-823.67%-2.05M

-116.70%-5.34M

-105.58%-1.1M

-111.99%-1.44M

-162.24%-3.09M

106.05%283K

1,948.38%31.98M

612.10%19.71M

-Change in receivables

-339.46%-3.71M

193.15%2.34M

106.63%147K

-141.80%-3.07M

-98.29%104K

-81.10%1.55M

-444.44%-2.51M

71.13%-2.22M

237.34%7.35M

343.92%6.1M

-Change in inventory

95.13%-55K

-25.51%768K

19.65%-965K

43.26%-989K

-67.16%310K

34.25%-1.13M

372.03%1.03M

-103.21%-1.2M

-10.53%-1.74M

180.34%944K

-Change in prepaid assets

-32.44%-788K

5.83%2.12M

-29.74%-253K

-7.79%1.29M

110.25%73K

-77.61%-595K

-25.00%2.01M

15.22%-195K

11.21%1.4M

-33.08%-712K

-Change in payables and accrued expense

153.44%1.21M

1.20%-2.89M

39.78%-589K

-4,677.03%-3.54M

90.09%-114K

-81.01%479K

-225.19%-2.92M

74.13%-978K

-119.42%-74K

-134.84%-1.15M

-Change in other working capital

14.57%-1.49M

-1,446.97%-10.71M

-107.96%-388K

-96.14%966K

-110.13%-1.47M

-152.71%-1.74M

-73.00%-692K

-35.89%4.87M

603.26%25.04M

7,515.31%14.53M

Cash from discontinued investing activities

Operating cash flow

-406.18%-11.88M

11.39%-7.01M

-217.79%-10.38M

35.02%-6.38M

-158.72%-4.94M

-183.55%-2.35M

-20.50%-7.91M

160.88%8.82M

70.23%-9.82M

204.40%8.42M

Investing cash flow

Cash flow from continuing investing activities

47.02%-80K

95.76%-35K

-1,350.00%-29K

60.58%-995K

38.46%-16K

91.21%-151K

-22.01%-826K

98.08%-2K

-176.45%-2.52M

95.12%-26K

Capital expenditure reported

47.02%-80K

95.76%-35K

-1,350.00%-29K

2.83%-995K

38.46%-16K

30.41%-151K

-22.01%-826K

98.08%-2K

-12.16%-1.02M

95.12%-26K

Net intangibles purchase and sale

----

--0

----

---1.5M

--0

Cash from discontinued investing activities

Investing cash flow

47.02%-80K

95.76%-35K

-1,350.00%-29K

60.58%-995K

38.46%-16K

91.21%-151K

-22.01%-826K

98.08%-2K

-176.45%-2.52M

95.12%-26K

Financing cash flow

Cash flow from continuing financing activities

-100.34%-17K

-60.09%1.71M

988.01%81.74M

-65.72%3.97M

1,572.22%3.91M

3,707.97%4.98M

-57.96%4.29M

-809.17%-9.21M

-61.50%11.59M

-95.71%234K

Net issuance payments of debt

-100.78%-8K

99.89%-5K

99.94%-5K

-1,010.47%-22.49M

-390.81%-9.94M

51.41%1.02M

-564.30%-4.48M

---9.09M

---2.03M

Net common stock issuance

--0

-59.49%1.69M

8,862.88%82.1M

-34.40%8.91M

-46.22%3.64M

-66.18%184K

-16.18%4.17M

-29.43%916K

-54.38%13.59M

30.38%6.76M

Proceeds from stock option exercised by employees

-95.98%193K

-99.16%30K

--539K

24,450.00%8.35M

99.56%-26K

120,100.00%4.8M

--3.57M

--0

-90.09%34K

-2,292.88%-5.86M

Net other financing activities

80.33%-202K

-100.49%-5K

13.72%-893K

306,833.33%9.2M

658.52%10.24M

---1.03M

--1.02M

---1.04M

78.57%-3K

135,100.00%1.35M

Cash from discontinued financing activities

Financing cash flow

-100.34%-17K

-60.09%1.71M

988.01%81.74M

-65.72%3.97M

1,572.22%3.91M

3,707.97%4.98M

-57.96%4.29M

-809.17%-9.21M

-61.50%11.59M

-95.71%234K

Net cash flow

Beginning cash position

300.56%89.87M

254.14%95.2M

-12.47%23.87M

-2.68%27.27M

33.61%24.92M

26.79%22.44M

82.42%26.88M

-2.68%27.27M

-11.89%28.02M

-40.16%18.65M

Current changes in cash

-582.75%-11.98M

-19.88%-5.33M

18,342.46%71.33M

-352.86%-3.4M

-112.12%-1.05M

160.06%2.48M

-250.25%-4.45M

97.06%-391K

80.15%-751K

374.65%8.62M

End cash Position

212.61%77.89M

300.56%89.87M

254.14%95.2M

-12.47%23.87M

33.61%24.92M

26.79%22.44M

82.42%26.88M

-2.68%27.27M

Free cash flow

-378.78%-11.96M

19.37%-7.04M

-218.14%-10.41M

40.25%-7.38M

-159.09%-4.96M

-328.75%-2.5M

-20.64%-8.73M

160.43%8.81M

63.58%-12.34M

197.63%8.39M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-405.96%-11.88M	11.39%-7.01M	-217.79%-10.38M	35.02%-6.38M	-158.71%-4.94M	-183.59%-2.35M	-20.50%-7.91M	160.88%8.82M	70.23%-9.82M	204.40%8.42M
Net income from continuing operations	-465.55%-11.51M	52.61%-2.75M	-259.00%-12.83M	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M
Operating gains losses	----	----	----	--1.03M	----	----	----	----	----	----
Depreciation and amortization	-39.54%159K	-29.07%205K	-36.31%207K	-43.65%1.35M	17.88%468K	-55.87%263K	-56.67%289K	-55.30%325K	-19.47%2.39M	-45.69%397K
Other non cash items	2,996.59%2.73M	4,430.77%2.36M	1,425.98%2.71M	-69.76%1.77M	3,492.59%1.83M	-96.05%88K	-97.25%52K	-111.49%-204K	-62.73%5.85M	-102.88%-54K
Change In working capital	-236.26%-4.83M	-170.85%-8.36M	-823.67%-2.05M	-116.70%-5.34M	-105.58%-1.1M	-111.99%-1.44M	-162.24%-3.09M	106.05%283K	1,948.38%31.98M	612.10%19.71M
-Change in receivables	-339.46%-3.71M	193.15%2.34M	106.63%147K	-141.80%-3.07M	-98.29%104K	-81.10%1.55M	-444.44%-2.51M	71.13%-2.22M	237.34%7.35M	343.92%6.1M
-Change in inventory	95.13%-55K	-25.51%768K	19.65%-965K	43.26%-989K	-67.16%310K	34.25%-1.13M	372.03%1.03M	-103.21%-1.2M	-10.53%-1.74M	180.34%944K
-Change in prepaid assets	-32.44%-788K	5.83%2.12M	-29.74%-253K	-7.79%1.29M	110.25%73K	-77.61%-595K	-25.00%2.01M	15.22%-195K	11.21%1.4M	-33.08%-712K
-Change in payables and accrued expense	153.44%1.21M	1.20%-2.89M	39.78%-589K	-4,677.03%-3.54M	90.09%-114K	-81.01%479K	-225.19%-2.92M	74.13%-978K	-119.42%-74K	-134.84%-1.15M
-Change in other working capital	14.57%-1.49M	-1,446.97%-10.71M	-107.96%-388K	-96.14%966K	-110.13%-1.47M	-152.71%-1.74M	-73.00%-692K	-35.89%4.87M	603.26%25.04M	7,515.31%14.53M
Cash from discontinued investing activities
Operating cash flow	-406.18%-11.88M	11.39%-7.01M	-217.79%-10.38M	35.02%-6.38M	-158.72%-4.94M	-183.55%-2.35M	-20.50%-7.91M	160.88%8.82M	70.23%-9.82M	204.40%8.42M
Investing cash flow
Cash flow from continuing investing activities	47.02%-80K	95.76%-35K	-1,350.00%-29K	60.58%-995K	38.46%-16K	91.21%-151K	-22.01%-826K	98.08%-2K	-176.45%-2.52M	95.12%-26K
Capital expenditure reported	47.02%-80K	95.76%-35K	-1,350.00%-29K	2.83%-995K	38.46%-16K	30.41%-151K	-22.01%-826K	98.08%-2K	-12.16%-1.02M	95.12%-26K
Net intangibles purchase and sale	----	----	----	--0	----	----	----	----	---1.5M	--0
Cash from discontinued investing activities
Investing cash flow	47.02%-80K	95.76%-35K	-1,350.00%-29K	60.58%-995K	38.46%-16K	91.21%-151K	-22.01%-826K	98.08%-2K	-176.45%-2.52M	95.12%-26K
Financing cash flow
Cash flow from continuing financing activities	-100.34%-17K	-60.09%1.71M	988.01%81.74M	-65.72%3.97M	1,572.22%3.91M	3,707.97%4.98M	-57.96%4.29M	-809.17%-9.21M	-61.50%11.59M	-95.71%234K
Net issuance payments of debt	-100.78%-8K	99.89%-5K	99.94%-5K	-1,010.47%-22.49M	-390.81%-9.94M	51.41%1.02M	-564.30%-4.48M	---9.09M	---2.03M	---2.03M
Net common stock issuance	--0	-59.49%1.69M	8,862.88%82.1M	-34.40%8.91M	-46.22%3.64M	-66.18%184K	-16.18%4.17M	-29.43%916K	-54.38%13.59M	30.38%6.76M
Proceeds from stock option exercised by employees	-95.98%193K	-99.16%30K	--539K	24,450.00%8.35M	99.56%-26K	120,100.00%4.8M	--3.57M	--0	-90.09%34K	-2,292.88%-5.86M
Net other financing activities	80.33%-202K	-100.49%-5K	13.72%-893K	306,833.33%9.2M	658.52%10.24M	---1.03M	--1.02M	---1.04M	78.57%-3K	135,100.00%1.35M
Cash from discontinued financing activities
Financing cash flow	-100.34%-17K	-60.09%1.71M	988.01%81.74M	-65.72%3.97M	1,572.22%3.91M	3,707.97%4.98M	-57.96%4.29M	-809.17%-9.21M	-61.50%11.59M	-95.71%234K
Net cash flow
Beginning cash position	300.56%89.87M	254.14%95.2M	-12.47%23.87M	-2.68%27.27M	33.61%24.92M	26.79%22.44M	82.42%26.88M	-2.68%27.27M	-11.89%28.02M	-40.16%18.65M
Current changes in cash	-582.75%-11.98M	-19.88%-5.33M	18,342.46%71.33M	-352.86%-3.4M	-112.12%-1.05M	160.06%2.48M	-250.25%-4.45M	97.06%-391K	80.15%-751K	374.65%8.62M
End cash Position	212.61%77.89M	300.56%89.87M	254.14%95.2M	-12.47%23.87M	-12.47%23.87M	33.61%24.92M	26.79%22.44M	82.42%26.88M	-2.68%27.27M	-2.68%27.27M
Free cash flow	-378.78%-11.96M	19.37%-7.04M	-218.14%-10.41M	40.25%-7.38M	-159.09%-4.96M	-328.75%-2.5M	-20.64%-8.73M	160.43%8.81M	63.58%-12.34M	197.63%8.39M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data